BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 23029871)

  • 1. Surfactant replacement in preterm infants with respiratory distress syndrome.
    Dani C
    Acta Biomed; 2012; 83 Suppl 1():17-20. PubMed ID: 23029871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive approach to the prevention of bronchopulmonary dysplasia.
    Kugelman A; Durand M
    Pediatr Pulmonol; 2011 Dec; 46(12):1153-65. PubMed ID: 21815280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant in the preterm infant: what's going on.
    Dani C; Barp J; Berti E; Bertini G
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():3-5. PubMed ID: 19925357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
    Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
    J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant and non invasive ventilation for preterm infants.
    Gizzi C; Papoff P; Campelli M; Cerasaro C; Agostino R; Moretti C
    Acta Biomed; 2012; 83 Suppl 1():24-6. PubMed ID: 23029873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory support in preterm infants at birth.
    ;
    Pediatrics; 2014 Jan; 133(1):171-4. PubMed ID: 24379228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of treatment with surfactant in premature infants with respiratory failure and pulmonary infection.
    Vento G; Tana M; Tirone C; Aurilia C; Lio A; Perelli S; Ricci C; Romagnoli C
    Acta Biomed; 2012; 83 Suppl 1():33-6. PubMed ID: 23029875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
    Engle WA;
    Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
    Robertson B
    Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity and mortality of neonatal respiratory failure in China: surfactant treatment in very immature infants.
    Wang H; Gao X; Liu C; Yan C; Lin X; Yang C; Lin Z; Zhu W; Yang Z; Yu F; Qiu Y; Liu X; Zhou X; Chen C; Sun B;
    Pediatrics; 2012 Mar; 129(3):e731-40. PubMed ID: 22331337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of respiratory distress syndrome: an update.
    Rodriguez RJ
    Respir Care; 2003 Mar; 48(3):279-86; discussion 286-7. PubMed ID: 12667277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal CPAP or intubation at birth for very preterm infants.
    Morley CJ; Davis PG; Doyle LW; Brion LP; Hascoet JM; Carlin JB;
    N Engl J Med; 2008 Feb; 358(7):700-8. PubMed ID: 18272893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous positive airway pressure and surfactant.
    Bohlin K; Jonsson B; Gustafsson AS; Blennow M
    Neonatology; 2008; 93(4):309-15. PubMed ID: 18525215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Respiratory failure in "late preterm" infants: a retrospective cohort study].
    Condò V; Colnaghi M; Vanzatiz M; Mercadante D; Pierro M; Vendettuoli V; Ronchi A; Mosca F
    Pediatr Med Chir; 2009; 31(6):241-5. PubMed ID: 20333882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
    Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
    Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
    Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early routine versus late selective surfactant in preterm neonates with respiratory distress syndrome on nasal continuous positive airway pressure: a randomized controlled trial.
    Kandraju H; Murki S; Subramanian S; Gaddam P; Deorari A; Kumar P
    Neonatology; 2013; 103(2):148-54. PubMed ID: 23235135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant replacement therapy in the neonate: beyond respiratory distress syndrome.
    Donn SM; Dalton J
    Respir Care; 2009 Sep; 54(9):1203-8. PubMed ID: 19712497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for INSURE failure in preterm infants.
    Dani C; Berti E; Barp J
    Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):19-20. PubMed ID: 21089712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.